Clinical Trial Update: Safety, Tolerability, Pharmacokinetic, Including Food Interaction, and Pharmacodynamic Profile of BIA 5-1058. [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety, tolerability, pharmacokinetics, including food interactions, and pharmacodynamics of BIA 5-1058 in hypertension and chronic hea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension

Drugs mentioned

• BIA 5-1058

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Hypertension and Chronic Heart Failure | Phase 1 | Status: COMPLETED | Results posted: 2016-01-05